Regulus Therapeutics Inc

NASDAQ RGLS

Download Data

Regulus Therapeutics Inc Market Capitalization on June 03, 2024: USD 144.68 M

Regulus Therapeutics Inc Market Capitalization is USD 144.68 M on June 03, 2024, a 436.62% change year over year. Market capitalization is a financial metric that represents the total value of a publicly traded company. It is calculated by multiplying the current share price of a company by the total number of outstanding shares. Market capitalization is used to assess the size and relative value of a company in the stock market. It provides investors with an idea of the company's overall worth and is often used as a basis for comparing companies within the same industry or sector. A higher market capitalization generally indicates a larger, more established company.
  • Regulus Therapeutics Inc 52-week high Market Capitalization is USD 188.54 M on March 27, 2024, which is 30.32% above the current Market Capitalization.
  • Regulus Therapeutics Inc 52-week low Market Capitalization is USD 22.85 M on January 17, 2024, which is -84.21% below the current Market Capitalization.
  • Regulus Therapeutics Inc average Market Capitalization for the last 52 weeks is USD 57.11 M.
NASDAQ: RGLS

Regulus Therapeutics Inc

CEO Mr. Joseph P. Hagan M.B.A.
IPO Date Oct. 4, 2012
Location United States
Headquarters 4224 Campus Point Court, San Diego, CA, United States, 92121
Employees 30
Sector Healthcare
Industry Biotechnology
Description

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Similar companies

VSTM

Verastem Inc

NA

NA

PULM

Pulmatrix Inc

NA

NA

CLRB

Cellectar Biosciences Inc

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email